<DOC>
	<DOCNO>NCT00555841</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety ALC treatment non-anemic , breast cancer subject develop moderate severe fatigue adjuvant radiotherapy .</brief_summary>
	<brief_title>Safety Efficacy ALC Breast Cancer Subjects With Fatigue</brief_title>
	<detailed_description>The objective study evaluate efficacy safety ALC treatment non-anemic , breast cancer subject develop moderate severe fatigue adjuvant radiotherapy</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<criteria>Stage 0III breast cancer adjuvant radiation indicate ; Qualifying Brief Fatigue Inventory ( BFI ) score 6 . Medication treat manage fatigue pain Use erythropoietin control anemia Clinical evidence hypothyroidism hyperthyroidism</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>breast cancer</keyword>
</DOC>